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Trivalent inorganic arsenic [As(III)] is a
known human carcinogen, with liver, skin
and lung as target sites (Abernathy et al.
1999). In solution at physiologic pH, As(III)
is primarily in the form of the undissociated
acid arsenic trioxide [As(OH)3] and not the
oxyanion arsenite (Ramirez-Solis et al. 2004).
The anhydrous form of arsenite trioxide
(As2O3) is also used clinically as a chemother-
apeutic agent for the treatment of acute
promyelocytic leukemia (Soignet et al. 1998).
In tissues of some mammalian species, As(III)
is methylated, forming trivalent and pentava-
lent products such as methylarsonous acid
[MAs(III)], methylarsonic acid [MAs(V)],
dimethylarsinous acid [DMAs(III)], dimethyl-
arsonic acid [DMAs(V)], trimethylarsine
oxide [TMAs(V)O] and trimethylarsine
[TMAs(III)] (Cullen et al. 1984; Waters et al.
2004a). The liver is considered a major site of
arsenic methylation, although other tissues
also have the capacity to methylate arsenic
(Vahter 2002). In humans, DMAs(III) and
DMAs(V) appear to be the end products of
this pathway (Thomas et al. 2001). MAs(III)
and DMAs(III) are significantly more cyto-
toxic than As(III), perhaps because they are
more potent inhibitors of critical enzymes
(Thomas et al. 2001) or more efﬁcient modu-
lators of signal transduction pathways that
regulate cellular metabolism and survival
(Drobna et al. 2003; Walton et al. 2004).
Thus, although the overall role of biomethyla-
tion in modulation of As(III) toxicity remains
unclear, it is possible that MAs(III) and
DMAs(III) signiﬁcantly contribute to adverse
effects associated with acute or chronic expo-
sure to As(III).
A mammalian As(III) methyltransferase,
Cyt19 or AS3MT, has been identiﬁed in rat
liver (Lin et al. 2002; Walton et al. 2003).
This enzyme catalyzes the sequential transfer of
methyl groups from S-adenosylmethionine to
trivalent arsenicals and the reduction of pen-
tavalent methylated intermediates in the meta-
bolic pathway for As(III) (Waters et al. 2004a,
2004b). The methylated arsenicals are released
from liver into the bloodstream and end up in
urine, skin, hair, and other tissues. For investi-
gators to understand the mechanisms of
arsenic toxicity and carcinogenesis as well as
the ability of arsenic to serve as a chemothera-
peutic agent, it is important to determine how
methylated arsenicals are transported out of
the liver and how they enter target tissues.
In this study, we show that aquaporin 9
(AQP9) conducts MAs(III). AQP9 is a mem-
ber of the aquaglyceroporin family of channels
that facilitates bidirectional movement of small
neutral solutes such as glycerol and urea (Agre
and Kozono 2003). Notably, the tissues with
the highest expression of AQP9 include the
liver (Abedin et al. 2002), an organ that plays a
key role in the metabolism of arsenic. AQP9 is
essential for the glycerol transport in the bile
ducts and ductules of the liver. We previously
identiﬁed the Escherichia coli aquaglyceroporin
GlpF as a channel for As(III) and trivalent
inorganic antimony [Sb(III)] (Meng et al.
2004; Sanders et al. 1997). In E. coli, uptake of
metalloids produces toxicity. In contrast, in
Sinorhizobium meliloti, downhill efflux of
internally generated As(III) by another
aquaglyceroporin, AqpS, confers resistance
(Yang et al. 2005). Thus, aqualglyceroporins
catalyze bidirectional movement of trivalent
arsenicals. In Saccharomyces cerevisiae, the
aquaglyceroporin Fps1p mediates uptake of
As(OH)3, producing sensitivity. We have
shown that rat AQP9, which has broadest
solute permeability (Borgnia et al. 1999)
among mammalian aquaglyceroporins, facili-
tates As(OH)3 transport when expressed in
frog oocytes or S. cerevisiae (Liu et al. 2002).
Thus, movement of arsenite appears to be a
ubiquitous property of aquaglyceroporin chan-
nels from prokaryotes to eukaryotes.
In solution at neutral pH, the most likely
form of MAs(III) is methanearsonous acid
[CH3As(OH)2], so it was reasonable to con-
sider the possibility that MAs(III) uses the same
translocation pathway as As(OH)3. Here, we
show that rat AQP9 conducts MAs(III). In
contrast, yeast Fps1p did not exhibit signiﬁcant
MAs(III) conductivity, demonstrating that
aquaglyceroporins have a wide variation in
selectivity for arsenicals. We examined the roles
of two speciﬁc residues in AQP9 in MAs(III)
transport by site-directed mutagenesis. From
the crystal structures of GlpF (Fu et al. 2000)
and AQP1 (Sui et al. 2001), it has been pro-
posed that the positive charge of GlpF residue
Arg-195 and AQP1 residue Arg-206 serve as
the ﬁlter that prevents movement of protons or
other positive ions (Jensen et al. 2003;
Tajkhorshid et al. 2002). In this study, we
showed that substitution of AQP9 residue
Arg-219 eliminates MAs(III) uptake, consistent
with a requirement for an arginine residue for
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Many mammals methylate trivalent inorganic arsenic in liver to species that are released into the
bloodstream and excreted in urine and feces. This study addresses how methylated arsenicals pass
through cell membranes. We have previously shown that aquaglyceroporin channels, including
Escherichia coli GlpF, Saccharomyces cerevisiae Fps1p, AQP7, and AQP9 from rat and human, con-
duct trivalent inorganic arsenic [As(III)] as arsenic trioxide, the protonated form of arsenite. One of
the initial products of As(III) methylation is methylarsonous acid [MAs(III)], which is considerably
more toxic than inorganic As(III). In this study, we investigated the ability of GlpF, Fps1p, and
AQP9 to facilitate movement of MAs(III) and found that rat aquaglyceroporin conducted MAs(III)
at a higher rate than the yeast homologue. In addition, rat AQP9 facilitates MAs(III) at a higher
rate than As(III). These results demonstrate that aquaglyceroporins differ both in selectivity for and
in transport rates of trivalent arsenicals. In this study, the requirement of AQP9 residues Phe-64
and Arg-219 for MAs(III) movement was examined. A hydrophobic residue at position 64 is not
required for MAs(III) transport, whereas an arginine at residue 219 may be required. This is similar
to that found for As(III), suggesting that As(III) and MAs(III) use the same translocation pathway
in AQP9. Identiﬁcation of MAs(III) as an AQP9 substrate is an important step in understanding
physiologic responses to arsenic in mammals, including humans. Key words: arsenic trioxide,
AQP9, aquaglyceroporin, methylarsonous acid. Environ Health Perspect 114:527–531 (2006).
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residue Phe-56 in AQP1 has been proposed to
orientate the water molecule to form a hydro-
gen bond with Arg-195 (de Groot and
Grubmuller 2001). The effect of substitution of
the corresponding residue in AQP9, Phe-64,
was investigated, and the results indicate that a
hydrophobic residue is not required at that
position. We propose that AQP9 is central to
arsenic metabolism in liver, and aquaglycero-
porins may play similar roles in other tissues.
As(III) enters the hepatocyte down its concen-
tration gradient through AQP9. Inside the cell,
As(III) is methylated and reduced to MAs(III).
Internally generated MAs(III) then ﬂows out of
the hepatocyte and into the bloodstream down
its concentration gradient via AQP9.
Materials and Methods
Strains and plasmids. E. coli and S. cerevisiae
strains and plasmids used in this study are
described in Table 1. Two E. coli strains were
used. The chromosomal arsRBC operon, which
confers low-level resistance to arsenite, had been
deleted to create the arsenic-hypersensitive
strain AW3110 (Carlin et al. 1995). Strain
OSBR1 was derived from AW3110 by inacti-
vation of the glpF gene. Disruption of glpF
makes the cells arsenite resistant again because
arsenite cannot get into the cells (Sanders et al.
1997). Similarly, two S. cerevisiae strains were
used. In yeast strain MG102, the YCF1 and
ACR3 genes encoding arsenite resistance trans-
porters were disrupted, rending the cells sensi-
tive to arsenite (Ghosh et al. 1999). Strain
HD9 was derived from MG102 by disruption
of the FPS1 gene (Liu et al. 2002), which
makes the yeast cells resistant to arsenite
because it is not taken up.
Chemicals and media. Methylarsine oxide
provided by W.R. Cullen (University of
British Columbia, Vancouver, Canada) was
used as a precursor of MAs(III). Methylarsine
oxide is hydrolyzed to MAs(III) in aqueous
solution (Petrick 2001). Sodium arsenite 
was purchased from Sigma Chemical Co.
(St. Louis, MO). S. cerevisiae strains were
grown at 30°C in minimal synthetic dextrose
(SD) medium (Adams et al. 1998) with 2%
galactose and supplemented with the required
auxotrophic requirements. E. coli cells were
grown in Luria-Bertani (LB) medium
(Sambrook et al. 1989) at 37°C.
DNA manipulations and site-directed
mutagenesis. Plasmid pAQP9 carrying the rat
AQP9 gene (Liu et al. 2002) was puriﬁed using
Qiagen miniprep spin column and used for
site-directed mutagenesis (Stratagene, La Jolla,
CA). Each mutation was verified by DNA
sequencing of the entire gene. The mutants
were transformed into yeast using a Geno easy-
transform kit (Geno Technologies, St. Louis,
MO). Oligonucleotides used were as follows:
R219E forward, GGG ACT GAG GTC TTC
AGC TGG GTT C; R219E reverse, GAA
CCC AGC TGA AGA CCT CAG TCC C;
R219H forward, GGG ACT GAG GTC ATG
AGC TGG GTT C; R219H reverse, GAA
CCC AGC TCA TGA CCT CAG TCC C.
Construction of the R219A, R219K, F64A,
F64W, and F64T mutants has been previously
described (Liu et al. 2004). Expression of each
mutant AQP9 protein was veriﬁed by sodium
dodecyl sulfate polyacrylamide gel electrophore-
sis and immunoblotting, as described previ-
ously (Liu et al. 2004).
Metal ion resistance assays. For E. coli,
strains were grown overnight at 37°C in liq-
uid LB medium with shaking, diluted into
LB with the indicated concentrations of met-
alloid, and allowed to grow with shaking for
an additional 8 hr. For S. cerevisiae, strains
were grown overnight at 30°C in liquid SD
medium with 2% galactose and the appropri-
ate supplements. The cultures were diluted
into fresh SD media to an optical density at
600 nm (OD600nm) of 0.2 in the presence of
varying concentrations of the metalloid salts
and incubated for an additional 20 hr, after
which growth was estimated from OD600nm.
For growth on solid media, yeast strains were
grown overnight at 30°C in liquid SD
medium with 2% galactose. Equivalent num-
bers of cells from each culture were spotted in
10-fold dilutions with the indicated concen-
trations of As(III) or MAs(III). Growth was
observed after 3 days of incubation at 30°C.
Transport assays. In vivo metalloid uptake
assays were performed as previously described
(Liu et al. 2002). Brieﬂy, either E. coli or yeast
cells were grown to exponential phase, har-
vested, washed with transport buffer consisting
of 75 mM HEPES, 0.15 M KCl, 1 mM
MgCl2, pH 7.3, and suspended to a density of
2 × 108 cells/mL in the same buffer containing
0.1 M glucose, all at room temperature. The
assay was initiated by addition of either 10 µM
Liu et al.
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Table 1. Strains and plasmids.
Strains/plasmids Genotype/description Source
E. coli strains
AW3110 ΔarsRB(C):cam F– IN(rrnD-rrnE) Carlin et al. 1995
OSBR1 AW3110 glpF::TnphoA, Kmr Sanders et al. 1997
S. cerevisiae strains
MG102 MATα ura3-52 his6 leu2-3,112 his3-Δ200 trp1-901 lys2-801 Ghosh et al. 1999
suc2Δycf1::hisG acr3::URA3
HD9 MATα ura3-52 his6 leu2-3,112 his3-Δ,200 trp1-901 lys2-801 Liu et al. 2002
suc2Δycf1::hisG acr3::URA3 fps1::leu2
Plasmids
pGEM-T E. coli cloning vector, Apr Promegaa
pYES3 S. cerevisiae–E. coli shuttle vector, Apr, TRP3 Invitrogenb
pFPS1 1941-bp PCR fragment containing FPS1 cloned in pYES3 Present results
pAQP9 1.1-kbp HindIII-KpnI fragment containing AQP9 cloned into Liu et al. 2002
HindIII-KpnI–digested pYES3
aPromega Corp., Madison, WI. bInvitrogen Corp., Carlsbad, CA.
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Figure 1. GlpF does not mediate MAs(III) uptake. (A) MAs(III) sensitivity in E. coli AW3110 (Δars) and OSBR1 (Δars ΔglpF). (B) Transport of MAs(III) by AW3110
and OSBR1. (C) Transport of As(III) by AW3110 and OSBR1. MAs(III) or As(III) was added at a ﬁnal concentration of 10 µM. Each point represents the mean of
three independent assays calculated using SigmaPlot 9.0 (Systat Software, Inc., Point Richmond, CA). Error bars indicate standard deviation.MAs(III) or 10 µM As(III), ﬁnal concentration.
Portions (0.1 mL) were withdrawn at intervals
and filtered through nitrocellulose filters
(0.5-µm pore size; Whatman Inc., Florham
Park, NJ). The ﬁlters were washed with 5 mL
of transport buffer 3 times and dried. The
membrane was treated in 70% nitrate acid at
70°C until dissolved, and HPLC-quality water
added to bring each sample to 7 mL. The
amount of arsenic was determined by induc-
tively coupled plasma mass spectrometry
(ICP-MS) (PerkinElmer, Norwalk, CT).
Results
MAs(III) uptake in E. coli. We have previously
shown that the aquaglyceroporin GlpF facili-
tates uptake of As(OH)3 in E. coli and that
deletion of GlpF results in loss of uptake
(Meng et al. 2004). Here we examined the
ability of GlpF to transport MAs(III). As(III)
and MAs(III) sensitivity and uptake were com-
pared in two E. coli strains. One was AW3110
(ΔarsRBC), in which the chromosomal arsRBC
operon, which confers resistance to both arsen-
ate and arsenite, was deleted. Thus, this strain
is hypersensitive to As(III). The second strain
was OSBR1 (ΔarsRBCΔglpF), which was
derived from AW3110 by disruption of the
gene for GlpF. Because this lacks the uptake
system for As(III), it is resistant to the metal-
loid. Both strains were sensitive to MAs(III)
(Figure 1A) and transported MAs(III) similarly
(Figure 1B). These data suggest that most
MAs(III) is taken up by a system or systems
other than GlpF, which accounts for the sensi-
tivity of E. coli to this methylated species. GlpF
participation in MAs(III) transport, if any, is
negligible. In contrast, AW3110 takes up
As(III), whereas OSBR1 does not (Figure 1C).
Because of the high rate of uptake of MAs(III),
it is not possible to conclude whether GlpF
conducts MAs(III).
MAs(III) uptake in S. cerevisiae by Fps1p
and mammalian AQP9. The ability of the
yeast aquaglyceroporin Fps1p to conduct
MAs(III) was examined. In these assays,
S. cerevisiae strains MG102 (acr3Δ ycf1Δ) and
HD9 (acr3Δ ycf1Δ fps1Δ) were used. MG102
is hypersensitive to As(III) because both ACR3,
which encodes a plasma membrane As(III)
extrusion carrier, and YCF1, which encodes a
homologue of the ATP binding cassette
ATPase multidrug resistance–associated pro-
tein (ABC ATPase MRP) (Cole et al. 1994)
and sequesters arsenite triglutathione [As(GS)3]
in the vacuole, were deleted (Ghosh et al.
1999). Like its parent, HD9 is acr3Δ ycf1Δ but
has become resistant to As(III) because it is also
fps1Δ and so does not take up As(III) (Liu et al.
2002). MG102 and HD9 exhibited similar
resistance to MAs(III), as did HD9 expressing
FPS1 from a plasmid (Figure 2A). However,
when rat AQP9 was expressed from a plasmid
in HD9, yeast cells became sensitive to
MAs(III).
The resistance phenotype could be related
to the ability of the cells to take up MAs(III).
Cells of MG102, HD9, or HD9 pFPS1took
up little MAs(III), but expression of rat AQP9
from a plasmid resulted in a high rate of uptake
of MAs(III) in HD9 (Figure 2B). Because
MG102 takes up considerably more As(III)
than does HD9 (Liu et al. 2002), these results
indicate that Fps1p facilitates uptake of 
As(III) but not MAs(III). In contrast, mam-
malian AQP9 takes up both inorganic and
monomethylated trivalent arsenic. Strikingly,
AQP9 conducts MAs(III) nearly 3 times faster
than it does As(III) (Figure 3). These results
indicate that AQP9 is more selective for the
monomethylated form than for the inorganic
form of trivalent arsenic, whereas Fps1p is
highly speciﬁc for the inorganic form. The abil-
ity of AQP9 to conduct MAs(III) at a higher
rate than As(III) is in good agreement with the
results of recent studies that show considerably
greater uptake and retention of MAs(III) than
As(III) in cultured mammalian cells (Dopp
et al. 2004; Drobna et al. 2005). Human
AQP9 is 75% identical to and exhibits 86%
overall similarity with the rat channel, and both
transport As(III) with similar rates (Liu et al.
2004), so it is reasonable to expect that the
human channel also conducts MAs(III).
However, the human enzyme does not express
well in yeast (Liu et al. 2004), so its ability to
conduct MAs(III) was not tested here.
Structure–function relationships in AQP9
transport of MAs(III). We addressed the ques-
tion of selectivity in aquaglyceroporins by muta-
genesis of residues predicted to be involved in
this process, including Arg-219, Trp-48, and
Phe-200 of AQP9. To examine the require-
ment for a positive charge for MAs(III) uptake,
Arg-219 was changed to alanine, lysine, gluta-
mate, and histidine. Similar amounts of wild-
type and mutant AQP9s were detected in the
yeast membranes by immunoblotting (data not
shown). HD9, which lacks the FPS1 gene, is
resistant to MAs(III) (Figure 4A) because it
MAs(III) transport by AQP9
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Figure 2. AQP9 but not FPS1 mediates MAs(III) uptake in yeast. (A) Sensitivity of strains MG102 (acr3Δ ycf1Δ),
HD9 (acr3Δ ycf1Δ fps1Δ), and HD9 pFPS1 or pAQP9 to MAs(III). (B) Transport of MAs(III) by MG102 and by
HD9 alone or with FPS1 or AQP9. MAs(III) was added at ﬁnal concentration of 10 µM. Each point represents
the mean of three independent assays calculated using SigmaPlot 9.0. Error bars indicate standard deviation.
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Figure 4. AQP9 Arg-219 is required for MAs(III)
transport. (A) Complementation of MAs(III) sensitiv-
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mutants. MAs(III) transport was assayed in strain
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bars indicate standard deviation.cannot take up the methylated metalloid
(Figure 4B). Expression of wild-type mouse
AQP9 renders cells of HD9 sensitive to
MAs(III) (Figure 4A) because the cells take up
MAs(III) (Figure 4B). Cells expressing any of
the mutants remained resistant to MAs(III)
(Figure 4A) and were unable to take up the
organic arsenical (Figure 4B). Although loss of
function in mutants could result from protein
misfolding, these results are consistent with an
arginine residue being required at position 219
for uptake of MAs(III) and suggest that
MAs(III) shares the same channel pathway as
As(III) and glycerol. 
We have previously shown that F64A,
F64T, and F64W AQP9s are expressed in yeast
and conduct As(III) and glycerol as well as
wild-type AQP9 (Liu et al. 2004). Each mutant
was transformed into yeast strain HD9, and
both MAs(III) sensitivity and uptake was com-
pared with HD9 transformed with wild-type
AQP9. Again, with only vector plasmid pYES3,
HD9 was resistant to MAs(III) and did not
accumulate the metalloid, whereas wild-type
AQP9 facilitated MAs(III) uptake and hence
rendered the cells sensitive (Figure 5). Yeast
cells expressing each of the Phe-64 mutants
was as sensitive to MAs(III) as cells expressing
wild-type AQP9 (Figure 5A). Cells expressing
each mutant accumulated MAs(III), although
at a somewhat lower rate than wild type
(Figure 5B). Although a hydrophobic channel
lining had been proposed to be required for
AQP function, these results demonstrate that a
hydrophobic residue at position 64 is not
required for MAs(III) transport.
Discussion
Aquaglyceroporins have been shown to facili-
tate uptake of As(III), including E. coli GlpF
(Sanders et al. 1997), S. cerevisiae Fps1p (Liu
et al. 2002; Wysocki et al. 2001), mouse AQP7
(Liu et al. 2002), and AQP9 from rat (Liu et al.
2002) and humans (Liu et al. 2004). Once
inside human cells, As(III) is methylated to a
variety of species, of which the monomethy-
lated form represents a signiﬁcant fraction of
total arsenic found in most tissues (Hughes
et al. 2003; Kenyon et al. 2005). The primary
site of methylation is liver, but other organs
such as kidney or testes may also methylate
As(III) (Healy et al. 1998). The ﬁnal fate of the
methylated species is excretion, both in urine
and in feces. How these compounds ﬁnd their
way from liver to other tissues such as blood,
kidney, or cecum is not certain, and the routes
of efﬂux of methylated arsenical from hepato-
cytes and uptake into other cell types are
unknown. In solution at physiologic pH, in-
organic trivalent arsenic is As(OH)3 (Ramirez-
Solis et al. 2004). We would predict that, in
solution, the monomethylated species would be
CH3As(OH)2, molecularly similar to but less
polar than As(OH)3. Because As(OH)3 is a
substrate of aquaglyceroporins, we considered
the possibility that those channels would also
conduct CH3As(OH)2. The answer was un-
expected in that the aquaglyceroporins exhibit
selectivity in their ability to facilitate transport
of trivalent arsenicals. AQP9 transports both
As(OH)3 and CH3As(OH)2 but is more selec-
tive for the latter. In contrast, neither GlpF nor
Fps1p exhibited any ability to facilitate
CH3As(OH)2 transport and yet are able to
transport As(III) as well as they do glycerol. It is
interesting to note that E. coli possesses an
endogenous uptake system for MAs(III),
whereas yeast does not.
What governs the selectivity of the
aquaglyceroporins for different trivalent arseni-
cals? In particular, what allows AQP9 to con-
duct MAs(III) when at least two other
aquaglyceroporins cannot? The structures of
GlpF and the strict water channel AQP1 have
been determined at atomic resolution. The
spacing at the narrowest region of the pore (the
aromatic/arginine ring) is signiﬁcantly wider in
GlpF [3.4 Å (Nollert et al. 2001)] compared
with AQP1 [2.8 Å in AQP1 (Sui et al. 2001)],
which accounts for the broader selectivity of
the aquaglyceroporin. As(OH)3 is a symmetri-
cal molecular with an O—O distance of
approximately 3 Å, just small enough to fit
through the GlpF channel. CH3As(OH)2 is
asymmetric compared with As(OH)3, and the
As—C bond is longer than the As—O bond,
which may account for the selectivity of GlpF.
Although its channel diameter is not known,
AQP9 transports a much wider range of sub-
strates than does GlpF, suggesting that larger
molecules may be able to traverse its channel.
Little is known about the relationship of
individual residues to the function of AQP9.
In members of the AQP superfamily, there is
often a conserved arginine after the second
asparagine–proline–alanine motif (Borgnia
et al. 1999). From analysis of the crystal struc-
tures of AQP1 and GlpF, it has been proposed
that the positive charge of this arginine residue
forms an electrostatic triangle with two nega-
tively charged residues to polarize the substrate
molecules and to provide a ﬁlter that prevents
charged molecules from entering the channel.
We have previously shown that a positive
Liu et al.
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Figure 6. Proposed pathways of trivalent arsenic transport in liver. Abbreviations: GSH, glutathione; SAM,
S-adenosylmethionine. Trivalent arsenic in the form of As(OH)3 ﬂows down a concentration gradient from
blood into hepatocytes through AQP9, which is the major aquaglyceroporin in liver (Carbrey et al. 2003). In
the cytosol of the hepatocyte, As(III) can be either glutathionylated or methylated to MAs(V), which is
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bers of the ABC superfamily of ATPases. Alternatively, As(III) can be methylated and reduced to
CH3As(OH)2, which then ﬂows down its concentration gradient via AQP9 into blood.MAs(III) transport by AQP9
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charge is required on the corresponding
residue in AQP9 (Arg-219) for both As(III)
and glycerol uptake (Liu et al. 2004). Our
results suggest that an arginine residue is pre-
ferred at position 219. In the structure of
GlpF, the aromatic rings of Trp-48 and
Phe-200 are perpendicular to each other and
form a hydrophobic corner that has been pro-
posed to serve as a selectivity ﬁlter (Lee et al.
2004). Corresponding to Trp-48 in AQP1 is
the hydrophobic residue Phe-56, which has
been proposed to orientate the water molecule
to form a hydrogen bond with Arg-195.
Because mutagenesis of the corresponding
hydrophobic residue in AQP9, Phe-64, was
not deleterious, a hydrophobic residue at this
position is not required.
AQP9 is highly expressed in liver (Abedin
et al. 2002), where it plays an essential role in
glycerol and urea transport (Carbrey et al.
2003). Because liver is also a key site for the
metabolism of arsenic, we propose a model in
which AQP9 catalyzes a key step in uptake of
As(III) and efflux of MAs(III) (Figure 6).
As(III) is taken up from the bloodstream by
hepatocytes via AQP9. Inside the hepatocyte,
it is methylated and reduced to MAs(III),
which has a number of possible fates. It can be
further methylated or glutathionylated. In
mammals, both As(GS)3 and methylarsenite
diglutathione [MAs(GS)2] are pumped into
bile by multidrug resistance–associated
protein 2 (MRP2) or homologues (Kala et al.
2000). Internally generated MAs(III) can also
ﬂow out of the cell down its concentration into
the bloodstream. AQP9 expression in rat liver
was induced up to 20-fold by fasting (Carbrey
et al. 2003), suggesting that uptake of As(III)
and redistribution of MAs(III) may be nutri-
tionally responsive. Once in the bloodstream,
MAs(III) can be redistributed into other tis-
sues, including blood cells and kidney, where it
is excreted. We predict that there are pathways
for uptake and excretion of di- and trimethy-
lated species (both tri- and pentavalent) as well,
and it is important to identify their transport
pathways. Identiﬁcation and characterization
of each transport system forms the basis for our
future studies.
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